In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

The U.S. Food and Drug Administration approved Novo Nordisk's weight-loss pill on Monday (December 22), giving the Danish ...

In that vein, experts suggest older adults prioritize the six pillars of movement: push, pull, carry, hinge, squat and overhead press to maintain day-to-day mobility as they age. Beginning around age ...

These days there is no escaping the popularity of taking a weight-loss drug to shed the pounds, and soon, it won’t even ...

As medical weight loss continues to evolve in 2026, the landscape of GLP-1 therapies has reached a pivotal moment with ...

People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...

A growing body of research suggests that older adults are discontinuing GLP-1 medications at high rates, The New York Times reported Dec. 21. Six things to know: 1. Sixty percent of Americans over age ...

New research reveals that taking a GLP-1 can be equivalent to '10 years of ageing' on the body, if proper precautions aren't ...

The popularity of weight-loss injections like Ozempic, Wegovy and Mounjaro has skyrocketed over the past two years, but alongside the impressive before-and-after results, a new question is emerging: ...

Asking your doctor how non-opioid pain-management options can help kickstart a smooth recovery and get you back to your ...

TORONTO — GLP-1 receptor agonists (RAs) have transformed diabetes and obesity management, offering improvements in glycemic control and weight loss and reductions in cardiometabolic risk. But “an ...